门冬氨酸-鸟氨酸联合乳果糖治疗肝性脑病疗效观察

来源 :中国药物经济学 | 被引量 : 0次 | 上传用户:zhmj1985
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观察门冬氨酸-鸟氨酸联合乳果糖治疗肝性脑病临床疗效。方法肝性脑病60例。随机分为两组。治疗组和对照组各30例。治疗组给予门冬氨酸-鸟氨酸静脉点滴注及乳果糖灌肠治疗。对照组给予谷氨酸钠或谷氨酸钾静滴。食醋灌肠。两组疗程10d。观察患者治疗前后的临床表现(症状和体征的变化)并检测血氨及肝肾功能判断临床疗效。结果 10d后治疗组血氨水平下降,肝肾功能指标恢复以及临床表现均优于对照组。结论门冬氨酸-鸟氨酸联合乳果糖能有效改善肝功能、降低血氨,显著提高肝性脑病的治愈率。值得临床推广使用。 Objective To observe the clinical efficacy of aspartate-ornithine combined with lactulose in the treatment of hepatic encephalopathy. Methods Hepatic encephalopathy in 60 cases. Randomly divided into two groups. The treatment group and the control group of 30 cases. The treatment group was given aspartate-ornithine intravenous infusion and lactulose enema treatment. The control group was given sodium glutamate or potassium glutamate intravenous infusion. Vinegar enema. Two groups of treatment 10d. Before and after treatment of patients with clinical manifestations (symptoms and signs of change) and detection of serum ammonia and liver and kidney function to determine the clinical efficacy. Results After 10 days, the level of serum ammonia decreased, the indexes of liver and kidney function recovered and the clinical manifestations were better than the control group. Conclusion Aspartate-Ornithine combined with lactulose can effectively improve liver function, lower blood ammonia, significantly improve the cure rate of hepatic encephalopathy. It is worth to promote clinical use.
其他文献
近日,记者从漳州水仙花基地获悉,从2008年12月下旬起,漳州水仙花一改之前销售不理想的形势,销售价格逐渐攀高,销量也大幅上升,农户手中的水仙花大部分已由销售商转到各地花
期刊
期刊
目的 探讨人类纤溶酶原激活物抑制物-1 (PAI-1) 基因4G/5G多态性与2型糖尿病(T2DM)患者股动脉内中膜厚度(FA-IMT)的关系.方法采用等位基因特异性多聚酶链式反应技术检测303例T2DM患者和93例健康个体PAI-1 基因4G/5G多态性,利用B型超声检测T2DM患者FA-IMT同时检测其代谢指标.结果 303例T2DM患者与93例健康对照基因型分布频率均符合Hardy-Wein
期刊
目的:观察特苏尼(托拉塞米)短期治疗慢性重度心衰的疗效。方法:选取60例慢性重症心衰患者,随机分为两组,一组予特苏尼10 mg,另一组为对照组,予呋塞米,治疗3 d,记录两组患者治
期刊
期刊